Does Lipitor's Patient Assistance Program Have Income Limits?
Yes, Pfizer's patient assistance program for Lipitor (atorvastatin) imposes income limits. Eligibility requires household income at or below 400% of the Federal Poverty Level (FPL), adjusted for family size and location. For 2024, this means a single-person household qualifies with income up to about $60,320 annually, rising to $124,800 for a family of four.[1][2]
How Do You Check Eligibility for Pfizer's Program?
Patients apply through Pfizer RxPathways, which covers Lipitor among other drugs. Requirements include U.S. residency, valid prescription, and no insurance coverage for the medication. Income verification uses tax returns or pay stubs; limits exclude certain deductions like childcare costs. Approval lasts up to 12 months, with recertification needed.[1][3]
What If Your Income Exceeds the Limit?
If over 400% FPL, explore Pfizer's co-pay savings card for commercially insured patients, which caps out-of-pocket costs at $10 per fill (up to $2,700 yearly savings). Uninsured patients above the limit may not qualify for free meds but can check state programs or generic atorvastatin options, now widely available off-patent.[2][4]
When Does Lipitor's Patent Expire and Why Does It Matter?
Lipitor's main composition patent expired in 2011, enabling generics that cost pennies per pill. Patient assistance now focuses on uninsured or underinsured gaps, but demand has dropped due to low generic prices. Check DrugPatentWatch.com for remaining secondary patents on formulations.[5]
Are There Alternatives to Pfizer's Program?
- GoodRx or SingleCare: Discount cards reduce generic Lipitor to $3–$10 per month without income checks.
- NeedyMeds or RxAssist: Aggregate programs; some statins qualify under broader funds.
- State pharmaceutical aid: Varies; e.g., California's program has its own income caps around 400% FPL.[3][4]
Sources
[1] Pfizer RxPathways Eligibility
[2] Pfizer Patient Assistance Income Guidelines
[3] NeedyMeds Pfizer Programs
[4] RxAssist Pfizer Listings
[5] DrugPatentWatch.com - Lipitor Patents